See every side of every news story
Published loading...Updated

Exero Medical scores $12.7M in funding and more digital funding news

Summary by MobiHealthNews
Exero Medical, a company focused on early detection of post-operative complications using tissue healing data, has secured up to $12.7 million in funding to complete its FDA trial and launch its breakthrough-designated xBar system in the United States.  The round includes $10 million in upfront funding and additional milestone-based warrants, as well as $2.7 million in non-dilutive grants. The round was led by Longevity Venture Partners, Tech Co…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MobiHealthNews broke the news in on Friday, February 14, 2025.
Sources are mostly out of (0)